Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-015026
Filing Date
2014-08-12
Accepted
2014-08-12 07:03:37
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q erb20140630_10q.htm 10-Q 798308
2 EXHIBIT 31.1 ex31-1.htm EX-31 9137
3 EXHIBIT 31.2 ex31-2.htm EX-31 9219
4 EXHIBIT 32.1 ex32-1.htm EX-32 5464
5 EXHIBIT 32.2 ex32-2.htm EX-32 5512
  Complete submission text file 0001437749-14-015026.txt   4516132

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS erb-20140630.xml EX-101.INS 641376
7 EXHIBIT 101.SCH erb-20140630.xsd EX-101.SCH 35320
8 EXHIBIT 101.CAL erb-20140630_cal.xml EX-101.CAL 38226
9 EXHIBIT 101.DEF erb-20140630_def.xml EX-101.DEF 173647
10 EXHIBIT 101.LAB erb-20140630_lab.xml EX-101.LAB 271792
11 EXHIBIT 101.PRE erb-20140630_pre.xml EX-101.PRE 174775
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127 305-324-2300
ERBA Diagnostics, Inc. (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14798 | Film No.: 141032403
SIC: 2834 Pharmaceutical Preparations